Compare Oscar Health Inc (OSCR) vs Synchrony Financial (SYF) Price & Performance

Oscar Health (OSCR) trades at $29.60, up 1.72% with mixed technical signals showing neutral overall momentum. The company reported strong Q1 2026 earnings beat but faces profitability challenges with negative margins. Revenue growth from $11.7B in 2025 to projected $13.3B in 2026 indicates expansion, while cash flow trends show operational improvement. Analyst consensus is divided with 27% buy ratings against a $24.67 price target below current levels.

The stock presents growth potential through revenue expansion and cash flow generation, but profitability concerns and negative ROE pose significant risks. Current valuation at 0.61 P/S suggests reasonable pricing for growth, though execution on margin improvement remains critical for sustained upside.

Synchrony Financial (SYF) trades at $73.41, down 0.29% on the day, with a bearish technical signal despite strong fundamentals. The stock shows robust profitability with a net income margin of 24.06% and ROE of 22.98%, supported by consistent earnings beats in recent quarters. Recent Q2 2026 results highlighted record purchase volume and a raised EPS outlook, though cash flow trends indicate a net outflow projection for 2026. Analyst consensus remains strongly bullish with a $86.38 price target.

The outlook for SYF is positive based on fundamental strength and analyst confidence, but near-term technical pressure and macroeconomic sensitivity pose risks. Investment appeal lies in its low P/E of 7.6 and dividend yield, though investors should monitor credit quality and interest rate impacts given its consumer lending focus.